MUMBAI, India, April 4 -- Intellectual Property India has published a patent application (202341065851 A) filed by Rk Pharma Inc., Orangetown, U.S.A., on Sept. 30, 2023, for 'ready-to-use injectable formulations of indocyanine green.'

Inventor(s) include Ravishanker Kovi; and Vure Prasad.

The application for the patent was published on April 4, under issue no. 14/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to ready to use injectable formulation of Indocyanine Green. The invention makes it possible to administer Indocyanine Green without reconstitution. The liquid formulation comprises Indocyanine Green and its pharmaceutically acceptable salts and pharmaceutically acceptable...